✦ LIBER ✦

Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs

✍ Scribed by Schmidt, Bradley R.; Glickman, Nita W.; DeNicola, Dennis B.; Gortari, Amalia E. de; Knapp, Deborah W.

Book ID: 119952006
Publisher: American Veterinary Medicine Association
Year: 2001
Tongue: English
Weight: 282 KB
Volume: 218
Category: Article
ISSN: 0003-1488
DOI: 10.2460/javma.2001.218.1783

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrospective evaluation of doxorubicin-

Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs

✍ Robat, C.; Burton, J.; Thamm, D.; Vail, D. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

RADIATION RESPONSE OF ORAL SQUAMOUS CELL

RADIATION RESPONSE OF ORAL SQUAMOUS CELL CARCINOMAS IN THE DOG

✍ Patrick R. Gavin 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Evaluation of glutathione in oral squamo

Evaluation of glutathione in oral squamous cell carcinoma

✍ S. M. Sharma; Muralee Mohan; Suchetha Kumari; Shreyas J. Sorake 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 75 KB

Results of the Combined Treatment with P

Results of the Combined Treatment with Piroxicam and Carboplatin in Canine Oral Non-Tonsillar Squamous Cell Carcinoma

✍ J. P. De Vos; A. G. D. Burm; B. P. Focker; H. Boschloo; M. Karsijns 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Treatment of squamous cell carcinoma of

Treatment of squamous cell carcinoma of the oral cavity

✍ Juan V. Fayos; Isadore Lampe 📂 Article 📅 1972 🏛 Elsevier Science 🌐 English ⚖ 967 KB

Salvage treatment for recurrent squamous

Salvage treatment for recurrent squamous cell carcinoma of the oral cavity

✍ Glenn J. Schwartz; Rajeev H. Mehta; Barry L. Wenig; Chitra Shaligram; Louis G. P 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Background. Squamous cell carcinoma (SCCA) of the oral cavity recurs with a frequency of 25%-48%, a fact that usually portends a poor prognosis. Recent studies have reported salvage cure rates as high as 67%. Investigators have also claimed that restaging recurrent tumors provides useful prognostic